The US albendazole anthelmintic drug market is supported by continued demand for treatments targeting parasitic worm infections, including hookworm, ascariasis, and pinworm infections. Albendazole remains an established prescription anthelmintic in the US, while increasing availability of generic products is influencing competition, pricing, and access. Recent evidence also indicates that...